Iridex (IRIX) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to -$0.09.
- Iridex's EPS (Weighted Average and Diluted) rose 2500.0% to -$0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.3, marking a year-over-year increase of 5522.39%. This contributed to the annual value of -$0.54 for FY2024, which is 847.46% up from last year.
- According to the latest figures from Q3 2025, Iridex's EPS (Weighted Average and Diluted) is -$0.09, which was up 2500.0% from -$0.06 recorded in Q2 2025.
- Iridex's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.1 during Q1 2022, with a 5-year trough of -$0.21 in Q1 2024.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.1, with a median of -$0.12 in 2024.
- In the last 5 years, Iridex's EPS (Weighted Average and Diluted) soared by 14500.0% in 2021 and then crashed by 25555.56% in 2022.
- Over the past 5 years, Iridex's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.14 in 2021, then surged by 50.0% to -$0.07 in 2022, then crashed by 157.14% to -$0.18 in 2023, then surged by 72.22% to -$0.05 in 2024, then tumbled by 80.0% to -$0.09 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.09 in Q3 2025, compared to -$0.06 in Q2 2025 and -$0.1 in Q1 2025.